Overview of the clinical results of pentasaccharide in major orthopedic surgery.
Turpie
A G
AG
HHS-General Hospital, Hamilton, Ontario, Canada. turpiea@mcmaster.ca
D017326:Clinical Trials, Phase III as Topic; D017984:Enoxaparin / Q000008:administration & dosage / Q000009:adverse effects; D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D000077425:Fondaparinux; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D011134:Polysaccharides / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D015996:Survival Rate; D013810:Therapeutic Equivalency; D013923:Thromboembolism / Q000188:drug therapy / Q000401:mortality / Q000517:prevention & control; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000188:drug therapy / Q000401:mortality / Q000517:prevention & control
D017984:Enoxaparin; D005343:Fibrinolytic Agents; D011134:Polysaccharides; D000077425:Fondaparinux